Trastuzumab emtansine
  • Chemical Properties
CAS No. 1018448-65-1 Cat. No. BCP30527
Name Trastuzumab emtansine
Synonyms Ado-trastuzumab emtansine；Kadcyla; trastuzumab-DM1; trastuzumab-MCC-DM1; trastuzumab-MCC-DM1 antibody-drug conjugate; T-DM1; PRO132365;
Formula M. Wt 148.5 kg/mol
  • Biological Activity
Description Trastuzumab emtansine is an antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab conjugated to the maytansinoid DM1 via a nonreducible thioether linkage (MCC) with potential antineoplastic activity. The trastuzumab moiety of this ADC binds to HER2 on tumor cell surface surfaces; upon internalization, the DM1 moiety is released and binds to tubulin, thereby disrupting microtubule assembly/disassembly dynamics and inhibiting cell division and the proliferation of cancer cells that overexpress HER2. Linkage of antibody and drug through a nonreducible linker has been reported to contribute to the improved efficacy and reduced toxicity of this ADC compared to similar ADCs constructed with reducible linkers. Check for active clinical trials or closed clinical trials using this agent.
  • Publications Citing
A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate

Publications Citing of Biochempartner's Trastuzumab emtansine(CAS:1018448-65-1)

Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
Service & Tech Support:orders@biochempartner.com
Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.